Raphael Rousseau - 07 Jan 2021 Form 4 Insider Report for Gritstone bio, Inc.

Role
Executive Vice President and Chief Medical Officer
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Raphael Rousseau
Issuer symbol
N/A
Transactions as of
07 Jan 2021
Net transactions value
$0
Form type
4
Filing time
19 Nov 2021, 16:42:56 UTC
Next filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Award $0 +29,700 $0.000000 29,700 07 Jan 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Remarks:

Executive Vice President and Chief Medical Officer